Jean-Marc Bellemin
2020 - Lion Biotechnologies
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Option Awards | $4,418,700 |
| Salary | $450,000 |
| Total | $4,998,700 |
Bellemin received $4.4M in option awards, accounting for 88% of the total pay in 2020.
Bellemin also received $130K in bonus and $450K in salary.
Rankings
In 2020, Jean-Marc Bellemin's compensation ranked 2,214th out of 13,090 executives tracked by ExecPay. In other words, Bellemin earned more than 83.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,214 out of 13,090 | 83rd |
Division Manufacturing | 849 out of 5,620 | 85th |
Major group Chemicals And Allied Products | 303 out of 2,253 | 87th |
Industry group Drugs | 258 out of 1,953 | 87th |
Industry Biological Products, Except Diagnostic Substances | 73 out of 411 | 82nd |
Pay ratio
| Jean-Marc Bellemin's Pay | $4,998,700 |
|---|---|
| Median Employee's Pay | $445,643 |
| Pay Ratio | 11to 1 |
In 2020, the annual total compensation of Jean-Marc Bellemin was $4,998,700.
The annual total compensation of the median employee at Lion Biotechnologies was $445,643.
The ratio of Jean-Marc Bellemin's pay to the pay of median employee was therefore 11 to one.
Bellemin's colleagues
We found five more compensation records of executives who worked with Jean-Marc Bellemin at Lion Biotechnologies in 2020.
2020
Maria Fardis
Lion Biotechnologies
Chief Executive Officer
2020
Frederick Vogt
Lion Biotechnologies
General Counsel
2020
Friedrich Finckenstein
Lion Biotechnologies
Chief Medical Officer
2020
Michael Swartzburg
Lion Biotechnologies
Former Vice President, Finance and interim Principal Financial Officer and Principal Accounting Officer
2020
Timothy Morris
Lion Biotechnologies